Botulinum toxin A for the management of temporomandibular myofascial pain: A cohort study.

Myofascial pain represents the largest subgroup of temporomandibular disorders (TMD) that account for a common cause of non-dental orofacial pain. The management of TMD is complex due to the chronic nature of the condition, alongside acute episodes presenting to the clinician. A fundamental part of TMD management is consideration of the biopsychosocial element in its aetiology.

The South Australia health chronic disease self-management Internet trial.

Objectives: To evaluate the effectiveness of an online chronic disease self-management program for South Australia residents.

Method: Data were collected online at baseline, 6 months, and 12 months. The intervention was an asynchronous 6-week chronic disease self-management program offered online.